Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources
Cancer Biomarkers Research Group

Publications

View All  |  2014-2010  |  2009-2004

  • Ankerst DP, Till C, Boeck A, Goodman P, Tangen CM, Feng Z, Partin AW, Chan DW, Sokoll L, Kagan J, Wei JT, Thompson IM. The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator. J Urol. 2013 Jul;190(1):70-6. Epub 2013 Jan 9.
    [ PubMed Abstract ]
  • Dunn BK, Srivastava S, Kramer BS. The word "cancer": how language can corrupt thought. BMJ. 2013 Sep 10;347.
    [ PubMed Abstract ]
  • Feng Z, Kagan J, Pepe M, Thornquist M, Ann Rinaudo J, Dahlgren J, Krueger K, Zheng Y, Patriotis C, Huang Y, Sorbara L, Thompson I, Srivastava S. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers Clin Chem. 2013 Jan;59(1):68-74. Epub 2012 Nov 27.
    [ PubMed Abstract ]
  • Pepper JA, Vydelingum NA, Dunn BK, FagerstromRM: Agent-Based Models in Cancer Prevention Research; in Agent-Based Models: Theory, Developments & Applications, (pp 105-116) Exit Disclaimer. Nova Science Publishers, Hauppauge, New York.
  • Shi T, Fillmore TL, Gao Y, Zhao R, He J, Schepmoes AA, Nicora CD, Wu C, Chambers JL, Moore RJ, Kagan J, Srivastava S, Liu AY, Rodland KD, Liu T, Camp DG 2nd, Smith RD, Qian WJ. Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis. Anal Chem. 2013 Oct 1;85(19):9196-203. Epub 2013 Sep 19.
    [ PubMed Abstract ]
  • Shi T, Gao Y, Quek SI, Fillmore TL, Nicora CD, Su D, Zhao R, Kagan J, Srivastava S, Rodland KD, Liu T, Smith RD, Chan DW, Camp DG 2nd, Liu AY, Qian WJ. A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum. J Proteome Res. 2013 Dec 3. [Epub ahead of print]
    [ PubMed Abstract ]
  • Shi T, Sun X, Gao Y, Fillmore TL, Schepmoes AA, Zhao R, He J, Moore RJ, Kagan J, Rodland KD, Liu T, Liu AY, Smith RD, Tang K, Camp DG 2nd, Qian WJ.J Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion. Proteome Res. 2013 Jul 5;12(7):3353-61. Epub 2013 Jun 13.
    [ PubMed Abstract ]
  • Srivastava S. Early Detection Research Network: 10-year outlook. Clin Chem. 2013 Jan;59(1):60-7.
    [ PubMed Abstract ]
  • Vydelingum NA, Sorbara L, Wagner P, Srivastava S. Standards in molecular diagnostics for the discovery and validation of clinically useful cancer biomarkers. Expert Rev Mol Diagn. 2013 Jun;13(5):421-3.
    [ PubMed Abstract ]
  • Ankerst DP, Koniarski T, Liang Y, Leach RJ, Feng Z, Sanda MG, Partin AW, Chan DW, Kagan J, Sokoll L, Wei JT, Thompson IM. Updating risk prediction tools: a case study in prostate cancer. Biom J. 2012 Jan;54(1):127-42.
    [ PubMed Abstract ]
  • Feng Z, Kagan J, Pepe M, Thornquist M, Rinaudo JA, Dahlgren J, Krueger K, Zheng Y, Patriotis C, Huang Y, Sorbara L, Thompson I, Srivastava S. The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers. Clin Chem. 2012 Nov 27. [Epub ahead of print] PubMed PMID: 23193062.
    [ PubMed Abstract ]
  • Kralj, Jason G, Arya, Chandamany, Tona, Alessandro, Forbes, Thomas P, Munson, Matthew S, Sorbara, Lynn, Srivastava, Sudhir and Forry, Samuel P. A simple packed bed device for antibody labelled rare cell capture from whole blood. Lab Chip, 2012, 12, 4972-4975.
    [ PubMed Abstract ]
  • Liu T, Hossain M, Schepmoes AA, Fillmore TL, Sokoll LJ, Kronewitter SR, Izmirlian G, Shi T, Qian WJ, Leach RJ, Thompson IM, Chan DW, Smith RD, Kagan J, Srivastava S, Rodland KD, Camp DG 2nd. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. J Proteomics. 2012 Aug 3;75(15):4747-57.
    [ PubMed Abstract ]
  • Prensner JR, Chinnaiyan AM, Srivastava S. Systematic, evidence-based discovery of biomarkers at the NCI. Clin Exp Metastasis. 2012 Oct;29(7):645-52.
    [ PubMed Abstract ]
  • Wagner PD, Srivastava S. New paradigms in translational science research in cancer biomarkers. Transl Res . 159:343-53, 2012.
    [ PubMed Abstract ]
  • Baum BJ, Yates JR 3rd, Srivastava S, Wong DT, Melvin JE. Scientific Frontiers: Emerging Technologies for Salivary Diagnostics. Adv Dent Res. 2011 Oct;23(4):360-8.
    [ PubMed Abstract ]
  • Cramer DW, Bast RC Jr, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, Sluss PM, Srivastava S, Ward DC, Zhang Z, Zhu CS, Urban N. Ovarian cancer biomarker performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial specimens. Cancer Prev Res (Phila). 2011 Mar;4(3):365-74.
    [ PubMed Abstract ]
  • Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) 4(3): 375-83, 2011.
    [ PubMed Abstract ]
  • Atha DH, Manne U, Grizzle WE, Wagner PD, Srivastava S, Reipa V. Standards for Immunohistochemical Imaging: A protein reference device for biomarker quantitation. J Histochem and Cytochem. 58:1005-14, 2010.
    [ PubMed Abstract ]
  • Baird CL, Fischer CJ, Pefaur NB, Miller KD, Kagan J, Srivastava S, Rodland KD. Developing recombinant antibodies for biomarker detection. Cancer Biomark. 2010;6(5-6):271-9.
    [ PubMed Abstract ]
  • Dunn BK, Wagner PD, Anderson D, Greenwald P. Molecular Markers for Early Detection. Semin Oncol. 37:224-242, 2010.
    [ PubMed Abstract ]
  • Grizzle WE, Srivastava S, Manne U. The biology of incipient, pre-invasive or intraepithelial neoplasia. Cancer Biomark. 2010;9(1-6):21-39.
    [ PubMed Abstract ]
  • Grizzle WE, Srivastava S, Manne U. Translational Pathology of Neoplasia. Cancer Biomark. 2010;9(1-6):7-20.
    [ PubMed Abstract ]
  • Patriotis, C., Maruvada, P. and Srivastava, S. Molecular Detection and Diagnosis of Cancer . In: The Molecular Basis of Human Cancer, 2 nd Edition. Humana Press.  2010.
  • Sokoll LJ, Sanda MG, Feng Z, Kagan J, Mizrahi IA, Broyles DL, Partin AW, Srivastava S, Thompson IM, Wei JT, Zhang Z, Chan DW. A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1193-200.
    [ PubMed Abstract ]
  • Srivastava S, Grizzle WE. Biomarkers and the genetics of early neoplastic lesions. Cancer Biomark. 2010;9(1-6):41-64.
    [ PubMed Abstract ]
  • Wang W, Srivastava S. Noncoding RNAs in molecular characterization of cancer preneoplasia. Cancer Biomark. 2010;9(1-6):133-40.
    [ PubMed Abstract ]
  • Wang W, Srivastava S. Strategic approach to validating methylated genes as biomarkers for breast cancer. Cancer Prev Res (Phila Pa). 2010;3(1):16-24. 136.
    [ PubMed Abstract ]